Cargando…
Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD
BACKGROUND. Secondary hyperparathyroidism (sHPT) represents an adaptive response to progressively impaired control of calcium, phosphorus and vitamin D in chronic kidney disease (CKD). It is characterized by parathyroid hyperplasia and excessive synthesis and secretion of parathyroid hormone (PTH)....
Autores principales: | Miller, Gerald, Davis, James, Shatzen, Edward, Colloton, Matthew, Martin, David, Henley, Charles M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363978/ https://www.ncbi.nlm.nih.gov/pubmed/22036941 http://dx.doi.org/10.1093/ndt/gfr589 |
Ejemplares similares
-
Association Between Resistance to Cinacalcet and Parathyroid Gland Hyperplasia in Kidney Transplant Recipients with Persistent Hypercalcemia
por: Oruc, A., et al.
Publicado: (2020) -
PSUN76 Massive Four-Gland Parathyroid Hyperplasia: The Case of the Missing Glands
por: Nicolich-Henkin, Sophie, et al.
Publicado: (2022) -
Right thyroid hemiagenesis with adenoma and hyperplasia of parathyroid glands -case report
por: Oruci, Merima, et al.
Publicado: (2012) -
Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients
por: Jäger, Mark D., et al.
Publicado: (2017) -
SAT-349 Cinacalcet Resistant Tertiary Hyperparathyroidism with One Large Parathyroid Gland
por: Chaker, Bayan, et al.
Publicado: (2020)